Sanofi will acquire Synthorx Inc to expand its immuno-oncology pipeline with THOR-707, an optimised IL-2 candidate.
Médecins Sans Frontières (MSF) called on the GAVI Vaccine Alliance not to pay huge subsidies to Big Pharma companies...
T cell agonist specialist ImCheck Therapeutics will use €48m (US$53m) from a Series B financing to push clincial...
Meatable NV, a specialist for cultivated meat, has raised an additional US$10m in seed funding, bringing the company’s...
Pierre Fabre SA and Puma Biotechnology, Inc. have broadened the geographic coverage of their license agreement on...
Despite challenging markets new players are entering the field to advance drug development in the fight against...
Scientists from the University of Washington are using the Phenoglyphs machine learning module to achieve faster high-content analysis through automation and simplification.
What can a cure cost?
It’s hard to put a price tag on a medical cure, particularly when it comes to gene therapies. To receive appropriate returns on investment,...